Abstract
Although the incidence (or at least the clinical presentation) of thyroid malignancies has been increasing in recent years, clinically significant thyroid cancers remain far less common than autoimmune thyroid diseases, Graves’ disease, and Hashimoto’s thyroiditis. Further, of the different pathological types of thyroid cancer, thyroid lymphomas are rare, representing less than 5% of thyroid neoplasms. Therefore, thyroid lymphomas are only encountered infrequently in clinical practice, for example, approximately two patients per year in a major referral center. Nevertheless, awareness and recognition of this condition are important because it is typically symptomatic and it may be amenable to therapy. Lymphomatous involvement of the thyroid gland can be localized to the gland (“primary”) or may be one component of more widespread lymphoma. This distinction may sometimes be blurred when the disease is primarily located in the thyroid but is also present to a limited extent in other regions, such as in lymph nodes adjacent to the thyroid. Viewed from another perspective, less than 1% of non-Hodgkin lymphomas present with primary thyroid involvement.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Thieblemont C, Mayer A, Dumontet C, Barbier Y, Callet-Bauchu E, Felman P, et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab. 2002;87:105–11.
Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. Semin Oncol. 1999;26:316–23.
Miller BS, Gauger PG. Thyroid lymphoma arising from Hashimoto’s thyroiditis. J Clin Endocrinol Metab. 2006;91:3711–12.
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Lymphoma classification: from controversy to consensus - the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol. 2000;11(1):3–10.
Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol. 2000;24:623–39.
Ruggiero FP, Frauenhoffer E, Stack Jr BC. Thyroid lymphoma: a single institution’s experience. Otolaryngol Head Neck Surg. 2005;133:888–96.
Koida S, Tsukasaki K, Tsuchiya T, Harasawa H, Fukushima T, Yamada Y, et al. Primary T-cell lymphoma of the thyroid gland with chemokine receptors of Th1 phenotype complicating autoimmune thyroiditis. Haematologica. 2007;92:e37–40.
Yang H, Li J, Shen T. Primary T-cell lymphoma of the thyroid: case report and review of the literature. Med Oncol. 2008;25:462–6.
Motoi N, Ozawa Y. Malignant T-cell lymphoma of the thyroid gland associated with Hashimoto’s thyroiditis. Pathol Int. 2005;55:425–30.
Kato I, Tajima K, Suchi T, Aozasa K, Matsuzuka F, Kuma K, et al. Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland. Jpn J Cancer Res. 1985;76:1085–90.
Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985;312:601–4.
McLachlan SM, McGregor A, Rees Smith B, Hall R. Thyroid-autoantibody synthesis by Hashimoto thyroid lymphocytes. Lancet. 1979;1(8108):162–3.
McLachlan SM, Rapoport B. The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in autoimmune thyroid disease. Endocr Rev. 1992;13:192–206.
Yamauchi A, Tomita Y, Takakuwa T, Hoshida Y, Nakatsuka S, Sakamoto H, et al. Polymerase chain reaction-based clonality analysis in thyroid lymphoma. Int J Mol Med. 2002;10:113–7.
Moshynska OV, Saxena A. Clonal relationship between Hashimoto thyroiditis and thyroid lymphoma. J Clin Pathol. 2008;61:438–44.
Lam KY, Lo CY, Kwong DL, Lee J, Srivastava G. Malignant lymphoma of the thyroid. A 30-year clinicopathologic experience and an evaluation of the presence of Epstein-Barr virus. Am J Clin Pathol. 1999;112:263–70.
Mack LA, Pasieka JL. An evidence-based approach to the treatment of thyroid lymphoma. World J Surg. 2007;31:978–86.
Hyjek E, Isaacson PG. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto’s thyroiditis. Hum Pathol. 1988;19:1315–26.
Chen HI, Akpolat I, Mody DR, Lopez-Terrada D, De Leon AP, Luo Y, et al. Restricted kappa/lambda light chain ratio by flow cytometry in germinal center B cells in Hashimoto thyroiditis. Am J Clin Pathol. 2006;125:42–8.
Wozniak R, Beckwith L, Ratech H, Surks MI. Maltoma of the thyroid in a man with Hashimoto’s thyroiditis. J Clin Endocrinol Metab. 1999;84:1206–9.
Lovchik J, Lane MA, Clark DP. Polymerase chain reaction-based detection of B-cell clonality in the fine needle aspiration biopsy of a thyroid mucosa-associated lymphoid tissue (MALT) lymphoma. Hum Pathol. 1997;28:989–92.
Hsi ED, Singleton TP, Svoboda SM, Schnitzer B, Ross CW. Characterization of the lymphoid infiltrate in Hashimoto thyroiditis by immunohistochemistry and polymerase chain reaction for immunoglobulin heavy chain gene rearrangement. Am J Clin Pathol. 1998;110:327–33.
Kato K, Ohshima K, Shiokawa S, Shibata T, Suzumiya J, Kikuchi M. Rearrangement of immunoglobulin heavy and light chains and VH family in thyroid and salivary gland lymphomas. Pathol Int. 2002;52:747–54.
Hummel M, Oeschger S, Barth TF, Loddenkemper C, Cogliatti SB, Marx A, et al. Wotherspoon criteria combined with B cell clonality analysis by advanced polymerase chain reaction technology discriminates covert gastric marginal zone lymphoma from chronic gastritis. Gut. 2006;55:782–7.
Saxena A, Alport EC, Moshynska O, Kanthan R, Boctor MA. Clonal B cell populations in a minority of patients with Hashimoto’s thyroiditis. J Clin Pathol. 2004;57:1258–63.
Laing RW, Hoskin P, Hudson BV, Hudson GV, Harmer C, Bennett MH, et al. The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and Royal Marsden Hospital. Clin Oncol (R Coll Radiol). 1994;6:300–4.
Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol. 2003;21:4157–64.
Basu S, Li G, Bural G, Alavi A. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility. Acta Radiol. 2009;50:201–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Rapoport, B., McLachlan, S.M. (2012). Thyroid Lymphoma. In: Braunstein, G. (eds) Thyroid Cancer. Endocrine Updates, vol 32. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0875-8_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0875-8_11
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-0874-1
Online ISBN: 978-1-4614-0875-8
eBook Packages: MedicineMedicine (R0)